ADHD tests for primary care

Our ADHD tests help healthcare practitioners in primary care ensure a rigorous and confident diagnostic process, facilitate robust referrals, and manage long waitlists.

A rigorous ADHD assessment for accurate and reliable diagnoses

Without data-driven, objective evidence on patients’ ADHD symptoms, it can be difficult to evaluate how robust your referrals are – especially as a patient’s first touchpoint. This is especially the case for those who are taking on a broader role in the diagnostic process, including those with special interest in neurodevelopmental conditions.

With our technology you can increase your clinical confidence and reduce the chances of potential misdiagnoses or delayed treatment. The AQUA study found that QbTest reduced the time to diagnostic decision by 44% and that clinicians were 77% more likely to be confident in ruling-out or diagnosing ADHD.

Streamlined and efficient assessment processes

Reduce time and resource constraints by streamlining the diagnostic process. According to the National Institute for Clinical Excellence (NICE), QbTest saves clinician time when used as part of ADHD assessments with no loss of accuracy.

The AQUA study also reported that the length of appointments was reduced by 15% and were 14 times more likely to rule out ADHD.

By standardizing the pathway, you can manage referrals more effectively without the need for additional staff or appointments. As shown in the LEAP project, our technology provides primary care providers with greater autonomy in managing routine assessments.

Comprehensive patient care and treatment measurement

ADHD management requires a holistic approach that includes treatment and ongoing monitoring. Our assessments support expert patient care by offering detailed insights into symptoms and progress throughout the pathway.

You have the insights to develop tailored treatment plans for your patients and monitor their effectiveness over time, ensuring everyone gets personalized and effective care.

Our technology captures 86% of patient’s treatment effects compared with only 37% of patient’s improvement captured by the ASRS rating scale. QbTest can distinguish pharmacological treatment effects within hours of medication optimization and can be used for monitoring of long-term treatment of ADHD.

Enhance patient and family communication

Effective communication with patients and their families is crucial for successful ADHD management. Our tests produce highly visual reports that are available immediately upon completion, acting as an anchor point for transparent discussions about diagnosis and treatment plans.

This improved communication helps patients and families understand the condition better, enhances treatment adherence, and builds trust in the care process.

Seamless integration into pathways

Our tests can be integrated into your existing pathway with the support of our expert clinical advisors who have hands-on experience in ADHD management.

This ensures a smooth transition and immediate enhancement of your practice’s diagnostic capabilities. The ease of integration means minimal disruption to your current processes while significantly improving the quality of ADHD assessments.

A reliable measure over time

With our FDA clearance covering ages 6-60, our technology serves as a consistent measure over time for ADHD patients under your care. In key life transitions like from childhood to adolescence, our reports offer insight into ADHD symptoms and help you to track changes, if any.

Most diagnostic tools fail to capture the challenges of this shift, meaning clinicians have limited information and patients can be left with overwhelming experiences.